The Neurovascular Surgery Program at UCLA is one of the leading research centers in the world for the diagnosis and treatment of vascular diseases of the brain and spinal cord.
For the past 20 years, UCLA cerebrovascular neurosurgeons have collaborated with colleagues in diagnostic neuroradiology, interventional neuroradiology, stroke neurology, neurological critical care, radiation/oncology, and neurological rehabilitation to treat more than 15,000 patients. We specialize in the management of coplex neurovascular disorders including aneurysms, moyamoya, arteriovenous malformations, cavernous malformations, and carotid artery stenosis. Our clinicians and researchers work as part of the UCLA Stroke Center, the first in Los Angeles County to earn accreditation as a JCAHO certified Comprehensive Stroke Center.
Through continuous research, the UCLA team developed a number of state-of-the-art treatments for cerebrovascular patients. The Guglielmi detachable coils were invented at UCLA, and revolutionized the treatment of intracranial aneurysms. The Merci clot-retrieval device was designed at UCLA, and is now approved by the FDA for restoration of blood flow to treat strokes. Ongoing research focuses on improving coils, refining microsurgical techniques, recovering from brain injury, managing ruptured aneurysms, brain mapping and monitoring, and the development of non-invasive four-dimensional imaging tools.
The Neurovascular Surgery Program at UCLA has been recognized by US News and World Report, which has always ranked UCLA Neurosurgery (with Neurology) as one of the top 10 such programs in the nation. As an academic center of excellence, patients are offered opportunities to participate in cutting-edge NIH-sponsored treatments. The Neurovascular team is constantly analyzing results to improve outcomes, and works tirelessly as they strive to provide the very best quality of care.